Friday, June 10, 2016
BioBridges, a career portfolio management company providing integrated services to the emerging life sciences community, is proud to announce their ongoing support for friend of BioBridges, Emily Quitzau, and her JettRide fundraiser.
14-year-old Emily Quitzau is a triplet with two brothers, both of whom were born with severe disabilities. Emily’s brother Calvin was diagnosed with Duchenne Muscular Dystrophy at age five, and over the years the degenerative muscle disease has confined him to a wheelchair with limited use of his arms.
Today the promise of new breakthroughs in research and treatment for Muscular Dystrophy offer new hope for the Duchenne community. Just last week the FDA delayed their decision on market approval for Sarepta Therapeutics’ drug, eteplirsen, which could be the first-ever Muscular Dystrophy drug in the United States. Still, Sarepta’s shares have been rising in anticipation that the delay suggests approval could be around the corner.
In the absence of unified institutional progress, individuals like Emily Quitzau have stepped up to raise money, awareness, and support for the fight against Duchenne. On July 22nd Emily will set off on JettRide, a tri-state, 500-mile bike ride far more grueling than the many triathlons and road races she has completed in the past to raise money and awareness for Duchenne.
While BioBridges has played an active role working on therapies for Duchenne Muscular Dystrophy, it was Emily’s remarkable personal story that truly inspired them to get behind her mission. “Sure, one could say our donation would suffice to support her cause,” says BioBridges Founding Partner, Jason Falchuk, “but we wanted to go a step further and get behind her in a bigger way by sharing her story with the greater BioBridges community.”
“Emily is an example for all of us,” Falchuk explains. “She reminds us of the courage, determination, and relentless strength it takes to face and overcome adversity.”
For more information and to donate to Emily’s JettRide, please visit her fundraising page.
Founded by industry veterans, BioBridges helps align exceptional life science professionals with the programs that need them. The company’s scalable consultant management model provides the experience that works, and delivers the contributions necessary to advance science and produce breakthrough therapies. For more information, please visit www.biobridges.com.